School of Medicine
Showing 10,261-10,280 of 12,906 Results
-
Edward Sheen
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioDr. Edward Sheen is Chief Quality and Population Health Executive at L.A. Care. Serving more than 2.9 million members, L.A. Care is the largest publicly operated health plan in the country. As a public entity, its mission is to provide access to quality care for vulnerable and low-income communities and to elevate the safety net. Previously, he was Chief Population Health Officer, Senior Vice President at Health Catalyst and Chief Medical Officer, Market Development and Solution Design at Lumeris, a leading value-based care technology and services operator as well as 4.5-5.0 Star Medicare Advantage plan. He has worked with health systems and payers across the country to improve health outcomes, enhance patient experience, strengthen care provider engagement, reduce costs of care, and accelerate their journey towards accountable care. He is dedicated to achieving accessible, equitable, person-centered, and high-performing care for all.
Dr. Sheen’s experience has bridged the public, private, non-profit, and academic sectors and additionally includes work with Stanford University, the White House, U.S. Department of Defense, U.S. Department of Health and Human Services, California State Assembly, Kaiser Family Foundation, Blue Shield, California and American Medical Associations, Genzyme, and early-stage companies. In 2014, he was one of 15 Americans appointed by President Obama a nonpartisan White House Fellow. He subsequently served as a Special Assistant to the Secretary of Defense and Defense Department senior health policy advisor and was a recipient of the Office of the Secretary of Defense Medal for Exceptional Public Service. Dr. Sheen was a Term Member of the Council on Foreign Relations. He currently serves on the National Advisory Council on the National Health Service Corps, which advises the Secretary of Health and Human Services and the California Department of Public Health Office of Health Equity Advisory Committee. He is Adjunct Professor of Medicine and Global Health Faculty Fellow at Stanford. He has a long-standing active commitment to mentoring, teaching, and medical education.
Dr. Sheen completed his Internal Medicine and Gastroenterology training at Stanford, received his MD from the University of California, San Francisco, and earned his MBA and MPH through scholarships at Stanford Graduate School of Business and Harvard School of Public Health, where he was also a Harvard Kennedy School Center for Public Leadership Zuckerman Fellow. He graduated magna cum laude from Brown University (B.A. Public Policy) with induction into Phi Beta Kappa. -
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Javaid I. Sheikh
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsMy research focuses on studying phenomenology, vulnerability factors, and psychiatric and medical comorbidity of panic disorder in old age, as well as treatment responses to medication in elders with panic disorder. I am presently involved in establishing and extending our preliminary finding that Late-Onset Panic Disorder (LOPD) (onset at or after age 55) is a phenomenologically distinct syndrome from Early-Onset Panic Disorder (EOPD).
-
Andrew A. Shelton, MD, FACS, FACRS
Clinical Professor, Surgery - General Surgery
Current Research and Scholarly InterestsMultimodality treatment of rectal cancer
Sphincter preserving procedures for rectal cancer
Laparoscopic colon and rectal surgery
Surgical education -
Dennis Shem
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Shem is a Clinical Assistant Professor in the Section of Dental Medicine and Surgery at Stanford University. He trained in Dental Oncology at Memorial Sloan Kettering Cancer Center, focusing on oral complications of cancer therapy and non-surgical management of patients with osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ). He also trained in Oral and Maxillofacial Pathology at Columbia University and has expertise in diagnosing and managing oral mucosal diseases.
As a dental oncologist and oral pathologist, he evaluates patients before and after organ and stem-cell transplant, radiation therapy, chemotherapy, and bisphosphonate therapy. He has particular interest in oral manifestations of systemic disease, oral complications of systemic therapy, and oral dysplasia. -
Andrew Shen
Ph.D. Student in Biomedical Data Science, admitted Autumn 2025
BioHi, my name is Andrew! I’m a current PhD student in Biomedical Data Science and an NSF Graduate Research Fellow. I am broadly interested in solving problems at the intersection of AI and science, but particularly in the areas of biology and medicine. Before my PhD, I worked at Harvard Medical School with Marinka Zitnik on developing machine learning methods for medicine and science.
Feel free to reach out to connect! -
Prof Christopher Shen MD
Adjunct Professor, Medicine - Surgery
Academic Staff - Hourly - CSL, SurgeryBioDr. Christopher Shen is an Adjunct Professor in the Stanford School of Medicine, the Director of Global Programs at the Stanford Mussallem Center for Biodesign, and a member of the Stanford Biodesign Leadership Council. Dr. Shen is also the Founding Executive Director of the Singapore Stanford Biodesign Program.
Dr. Shen has been a longstanding member of the Stanford community since 1991, completing degrees in Biological Sciences, Biomechanical Engineering, Business, and Medicine. He has been teaching graduate and undergraduate students since 2001.
A strong proponent of interdisciplinary and experiential education, Dr. Shen has dedicated his career to teaching medical, engineering, and business students at Stanford and abroad in foundational concepts underpinning design-thinking, clinical immersion, ideation, rapid prototyping, innovation, and entrepreneurship. In addition, Dr. Shen is responsible for establishing and/or managing collaborations between Stanford and Biodesign-like programs on every continent except Antarctica! He continues to annually mentor diverse groups of students to develop and implement innovative medical solutions to serve patients around the world.
Dr. Shen is the founding and current U.S. Executive Director of Singapore Stanford Biodesign since its inception in 2010. As the first Biodesign program in East Asia, its mission is to train the next generation of medical technology innovators throughout the Pacific Rim, focusing on the unique medical needs in the region. Supported by Singapore's national level research institute, the Agency for Science, Technology, and Research (ASTAR), and the National Research Foundation (NRF), the program has uniquely built bridges across Asia, spanning Singapore, China, Indonesia, Taiwan, Korea, Australia, and Malaysia. In total, the program has trained 60 Fellows and hundreds of students throughout the region.
Dr. Shen is also a Partner at Novo Holdings, the asset manager of the Novo Foundation, one of the largest philanthropic organizations in the world. With headquarters in Denmark, Novo Holdings is committed to investing in innovative companies that improve the health of people and planet. Dr. Shen started his career in medical innovation as a Senior Design Engineer at Guidant Neurovascular, where he was the principal inventor of one of the original stentriever devices for ischemic stroke. He has been issued twelve patents in the fields of interventional neuroradiology and interventional cardiology.
Dr. Shen was a Stanford Asia/Pacific Scholar and a Paul & Daisy Soros Fellow.
